In rare cases, GLP-1 medication can also cause low blood sugar levels
Two-way repeated measures ANOVA was used to compare blood ethanol concentration between the two groups over the five-time points, considering group and time as factors
Diabetes Educ 15(3):236241
Recent studies have shown that GLP-1 is a physiological regulator of appetite and food intake which assist in weight loss
Evidencia clnica en humanos La ALCAR tiene literatura clnica en varios contextos: Funcin cognitiva en adultos mayores: estudios han mostrado mejoras en pruebas de memoria y atencin en personas mayores con deterioro cognitivo leve, particularmente a dosis de 1,500-3,000 mg/da durante 3-6 meses 4
This approach exists for a specific reason: starting at a higher dose produces stronger side effects, particularly nausea and digestive discomfort, that make treatment difficult to tolerate and sustain